Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

NCT00388154 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

M.D. Anderson Cancer Center